Immunology chapter whole notes point wise easily explained
| Component | Examples |
|---|---|
| Cellular barriers | Skin, mucosal epithelia |
| Chemical barriers | Antimicrobial peptides (defensins), lysozyme |
| Secreted proteins | Complement, collectins (MBL), pentraxins |
| Phagocytes | Macrophages, neutrophils |
| Other cells | Dendritic cells, Natural Killer (NK) cells, mast cells, innate lymphoid cells (ILCs) |
| Pathway | Antigen Source | MHC Class | T Cell |
|---|---|---|---|
| Endogenous (cytosolic) | Intracellular (viruses) | Class I | CD8βΊ CTL |
| Exogenous (vesicular) | Extracellular (bacteria) | Class II | CD4βΊ Helper T |
| Cross-presentation | Extracellular β Class I | Class I | CD8βΊ CTL |
| Class | Key Features |
|---|---|
| IgG | Most abundant; crosses placenta; long-term immunity; 4 subclasses |
| IgM | First produced in primary response; pentamer; activates complement |
| IgA | Found in secretions (saliva, tears, breast milk, gut); dimer form; mucosal immunity |
| IgE | Allergy and anti-parasite immunity; binds mast cells and basophils |
| IgD | Mainly on naΓ―ve B cells as antigen receptor; function less clear |
| Pathway | Trigger | Key Protein |
|---|---|---|
| Classical | Antibody (IgG/IgM) bound to antigen | C1q detects Fc; C1r, C1s activate |
| Alternative | Direct recognition of microbial surfaces (e.g., LPS) | C3 directly activates; no antibody needed |
| Lectin (MBL) | Mannose residues on microbes | Mannose-Binding Lectin (MBL) + MASP1/MASP2 |
| Cytokine | Source | Function |
|---|---|---|
| IL-2 | T cells | T cell proliferation (autocrine) |
| IL-4 | Th2 cells | B cell activation; IgE class switch; allergy |
| IL-5 | Th2 cells | Eosinophil activation |
| IL-10 | Tregs, macrophages | Anti-inflammatory |
| IL-12 | Macrophages, DCs | NK cell activation; drives Th1 differentiation |
| IL-17 | Th17 cells | Neutrophil recruitment; mucosal defense |
| IFN-Ξ³ | Th1, NK cells | Macrophage activation; antiviral |
| TNF-Ξ± | Macrophages | Inflammation; fever; septic shock at high levels |
| TGF-Ξ² | Tregs, many cells | Immunosuppression; Treg induction |
| Subset | Inducing Cytokines | Key Cytokines Produced | Function |
|---|---|---|---|
| Th1 | IL-12, IFN-Ξ³ | IFN-Ξ³, TNF | Macrophage activation; intracellular pathogens |
| Th2 | IL-4 | IL-4, IL-5, IL-13 | B cell help; allergy; anti-helminth |
| Th17 | TGF-Ξ² + IL-6 | IL-17, IL-22 | Mucosal defense; fungi/bacteria; autoimmunity |
| Treg | TGF-Ξ² | IL-10, TGF-Ξ² | Suppression; self-tolerance; prevent autoimmunity |
| Tfh | IL-21, IL-6 | IL-21 | Help B cells in germinal centers β high-affinity Ab |
| Feature | Active Immunity | Passive Immunity |
|---|---|---|
| How acquired | Response to antigen (infection or vaccine) | Transfer of antibodies or T cells from immunized donor |
| Onset | Slow (daysβweeks) | Rapid (immediate) |
| Duration | Long-lasting (memory) | Short-lived (no memory) |
| Examples | Natural infection, vaccines | Maternal IgG to fetus (transplacental), anti-toxin sera, IVIG |
| Memory | Yes | No |
| Type | Mechanism | Mediators | Examples |
|---|---|---|---|
| Type I (Immediate) | IgE on mast cells/basophils β allergen cross-links IgE β degranulation | Histamine, leukotrienes, prostaglandins | Anaphylaxis, asthma, allergic rhinitis |
| Type II (Cytotoxic) | IgG/IgM against cell surface antigens | Complement, ADCC, phagocytosis | Autoimmune hemolytic anemia, Goodpasture syndrome |
| Type III (Immune complex) | IgG/IgM antigen-antibody complexes deposit in tissues | Complement, neutrophils | SLE, serum sickness, post-strep GN |
| Type IV (Delayed/DTH) | Sensitized T cells (CD4βΊ Th1 or CD8βΊ CTL) | IFN-Ξ³, macrophage activation | TB (Mantoux test), contact dermatitis, graft rejection |
| Disease | Defect | Features |
|---|---|---|
| X-linked Agammaglobulinemia (XLA) | BTK gene; no B cells | Recurrent bacterial infections; β all Ig |
| SCID (Severe Combined Immunodeficiency) | T + B cell defects (various causes) | Infections from birth; viral, fungal, bacterial |
| DiGeorge Syndrome | Thymic aplasia (22q11 deletion) | No T cells; recurrent viral/fungal infections |
| Selective IgA deficiency | β IgA | Most common primary; mucosal infections |
| Chronic Granulomatous Disease (CGD) | NADPH oxidase defect in phagocytes | Catalase+ organisms (S. aureus, Aspergillus) |
| Type | Mechanism | Examples |
|---|---|---|
| Live attenuated | Weak live pathogen β strong T+B response + memory | MMR, BCG, oral polio, varicella |
| Killed/Inactivated | Dead pathogen β humoral response | Flu (injectable), Hepatitis A, Salk polio |
| Subunit/Toxoid | Purified antigen or inactivated toxin | HBV, Pertussis (acellular), Tetanus, Diphtheria |
| mRNA vaccines | mRNA β antigen production in host cells β immune response | COVID-19 (Pfizer, Moderna) |
| Conjugate | Polysaccharide linked to protein carrier for T-dependent response | Hib, PCV, MenACWY |
| Concept | Key Point |
|---|---|
| Innate vs. Adaptive | Innate = fast, non-specific; Adaptive = slow, specific, memory |
| B cells | Bone marrow; make antibodies; humoral immunity |
| T cells | Thymus; CD4βΊ helper, CD8βΊ cytotoxic; cell-mediated immunity |
| MHC I vs. II | I = all cells, CD8; II = APCs only, CD4 |
| Complement | 3 pathways β C3b (opsonin) + MAC (lysis) + C3a/C5a (inflammation) |
| IgG | Most abundant; crosses placenta; long-term |
| IgM | First responder; activates complement |
| IgA | Secretory; mucosal surfaces |
| IgE | Allergy + anti-parasite |
| Type I hypersensitivity | IgE β mast cell degranulation β anaphylaxis |
| Type IV hypersensitivity | T cell mediated; delayed (48-72h); TB test |
| Central tolerance | Clonal deletion in thymus/bone marrow |
| Peripheral tolerance | Anergy, Tregs, ignorance |
| Immunologic memory | Basis of vaccination; faster secondary response |
Immunity (innate and acquired) detailed notes easily explained
| Cell | Location | Function |
|---|---|---|
| Neutrophils | Blood β tissues | First to arrive at infection; phagocytosis + killing |
| Macrophages | Tissue-resident | Phagocytosis, cytokine production, antigen presentation |
| Dendritic Cells (DCs) | Tissues, especially skin | Sentinel cells; link innate to adaptive immunity |
| Natural Killer (NK) cells | Blood, tissues | Kill virus-infected and tumor cells without prior sensitization |
| Mast cells | Skin, mucosa | Release histamine; trigger inflammation and allergy |
| Basophils | Blood | Similar to mast cells; anti-parasite; allergy |
| Eosinophils | Blood, tissues | Kill parasites; involved in allergy |
| Innate Lymphoid Cells (ILCs) | Tissues | Cytokine production; rapid effector response |
| Receptor | Location | Ligand Recognized |
|---|---|---|
| TLRs (Toll-Like Receptors) | Plasma membrane + endosomes | LPS, flagellin, viral RNA/DNA |
| NLRs (NOD-Like Receptors) | Cytoplasm | Bacterial fragments, uric acid, ATP |
| RLRs (RIG-I-Like Receptors) | Cytoplasm | Viral dsRNA |
| CLRs (C-type Lectin Receptors) | Plasma membrane | Mannose, Ξ²-glucan (fungi) |
| Cytosolic DNA sensors | Cytoplasm | Microbial or self DNA in wrong location |
| Pathway | Trigger | First Step |
|---|---|---|
| Classical | IgG or IgM antibody bound to antigen | C1q binds Fc region β C1r, C1s activate |
| Alternative | Microbial surfaces directly (LPS, fungal walls) | C3 binds spontaneously, amplified on microbes |
| Lectin (MBL) | Mannose residues on microbes | MBL + MASP1/MASP2 activate downstream cascade |
| Feature | Explanation |
|---|---|
| Specificity | Each lymphocyte recognizes ONE specific antigen (or epitope) |
| Diversity | Can recognize ~10β·β10βΉ different antigens; generated by V(D)J recombination |
| Memory | Long-lived memory cells persist after infection clears; faster re-response |
| Self-tolerance | Does NOT attack self tissues (failure = autoimmunity) |
| Clonal expansion | When antigen binds its specific lymphocyte, that clone proliferates enormously |
| T Cell Type | Surface Marker | Function |
|---|---|---|
| CD4βΊ Helper T cells | CD4 | Secrete cytokines; help B cells make antibodies; help macrophages kill ingested microbes |
| CD8βΊ Cytotoxic T cells (CTL) | CD8 | Kill virus-infected cells and tumor cells directly |
| Regulatory T cells (Treg) | CD4 + FoxP3 | Suppress immune responses; prevent autoimmunity |
| Class | Structure | Key Function | Notable |
|---|---|---|---|
| IgG | Monomer | Opsonization, ADCC, complement | Crosses placenta; most abundant in blood (75%) |
| IgM | Pentamer | Primary response; complement activation | First antibody made; most effective complement activator |
| IgA | Dimer (secretory) | Mucosal immunity | In saliva, tears, breast milk, gut secretions |
| IgE | Monomer | Allergy; anti-parasite | Binds mast cells/basophils; triggers anaphylaxis |
| IgD | Monomer | B-cell receptor; naΓ―ve B cell | Role in immune signaling; very low serum levels |
| Cytokine | Produced By | Action |
|---|---|---|
| IL-2 | T cells | T cell proliferation (autocrine); NK cell growth |
| IL-4 | Th2 cells | B cell activation; IgE class-switch; allergy |
| IL-5 | Th2 cells | Eosinophil differentiation and activation |
| IL-17 | Th17 cells | Neutrophil recruitment; mucosal defense |
| IFN-Ξ³ | Th1, NK cells | Macrophage activation; antiviral; inhibits Th2 |
| TGF-Ξ² | Tregs | Immunosuppression; tolerance; Treg induction |
| IL-10 | Tregs, macrophages | Anti-inflammatory; limits immune damage |
| TNF-Ξ± | Macrophages, T cells | Pro-inflammatory; fever; acute phase response |
| Feature | Primary Response | Secondary (Memory) Response |
|---|---|---|
| Onset | 5β10 days | 1β3 days |
| Peak antibody | Lower | Much higher |
| Antibody type | IgM first, then IgG | Predominantly IgG |
| Affinity | Lower | Higher (affinity maturation) |
| Duration | Shorter | Longer |
| Feature | Active Immunity | Passive Immunity |
|---|---|---|
| How induced | By antigen exposure (natural or vaccine) | Transfer of antibodies from another person/animal |
| Onset | Slow (days to weeks) | Immediate |
| Duration | Long-lasting (years, lifetime) | Short (weeks to months β as antibodies decay) |
| Memory | Yes | No |
| Examples β Natural | Recovery from measles | Maternal IgG across placenta; breast milk IgA |
| Examples β Artificial | Vaccines (all types) | Antitoxins, IVIG, rabies immune globulin, snake antivenom |
| Feature | Innate Immunity | Acquired (Adaptive) Immunity |
|---|---|---|
| Timing | Minutes to hours | Days to weeks (primary); hours (secondary) |
| Specificity | Broad β classes of microbes (PAMPs) | Highly specific β individual antigens/epitopes |
| Diversity | ~100 receptors recognizing ~1000 patterns | 10β·β10βΉ unique specificities via gene recombination |
| Memory | None (or minimal) | Yes β hallmark feature |
| Key cells | Neutrophils, macrophages, NK cells, DCs, mast cells | T lymphocytes, B lymphocytes |
| Key molecules | Complement, interferons, acute-phase proteins | Antibodies (Ig), cytokines, TCR/BCR |
| Recognition | Germline-encoded PRRs (TLRs, NLRs) | Somatically-generated BCR and TCR |
| Self-tolerance | Yes (limited mechanisms) | Yes (central + peripheral tolerance) |
| Improvement with exposure | No | Yes |
| Role in vaccines | Initial activation | Generates memory that protects |
| Against intracellular pathogens | NK cells, interferons | CD8βΊ CTL, Th1-mediated macrophage activation |
| Against extracellular pathogens | Phagocytosis, complement | Antibodies (IgG, IgM, IgA) |
Immunity (innate and acquired) detailed notes easily explained